OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
30
Results
Show all
Save search
Copy query
Show results for
Unknown
(30)
Publication Date
Release Date
2021
(6)
2022
(4)
2020
(4)
2024
(3)
2023
(2)
2018
(2)
2017
(2)
2016
(2)
2015
(2)
2025
(1)
2014
(1)
2012
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Full optimization of dynamic nuclear polarization on a 1 tesla benchtop polarizer with hyperpolarizing solids.
Not available
S-EPMC11307143
|
biostudies-literature
Cite
Boosting <sup>1</sup>H and <sup>13</sup>C NMR signals by orders of magnitude on a bench.
Not available
S-EPMC11616688
|
biostudies-literature
Cite
Solid-state
1
H spin polarimetry by
13
CH
3
nuclear magnetic resonance.
Not available
S-EPMC10539844
|
biostudies-literature
Cite
Galectin-3 modulates epithelial cell adaptation to stress at the ER-mitochondria interface.
Not available
S-EPMC7217954
|
biostudies-literature
Cite
Dipolar order mediated 1H → 13C cross-polarization for dissolution-dynamic nuclear polarization
Not available
S-EPMC10500725
|
biostudies-literature
Cite
Fremy's Salt as a Low-Persistence Hyperpolarization Agent: Efficient Dynamic Nuclear Polarization Plus Rapid Radical Scavenging.
Not available
S-EPMC9673139
|
biostudies-literature
Cite
Diseases associated with calcium-sensing receptor.
Not available
S-EPMC5264458
|
biostudies-literature
Cite
Spin Noise Detection of Nuclear Hyperpolarization at 1.2 K.
Not available
S-EPMC4691331
|
biostudies-literature
Cite
Rare Forms of Lipomatosis: Dercum's Disease and Roch-Leri Mesosomatous Lipomatosis.
Not available
S-EPMC8003963
|
biostudies-literature
Cite
Metabolic and immunological phenotype of rare lipomatoses: Dercum's disease and Roch-Leri mesosomatic lipomatosis.
Not available
S-EPMC8243498
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets